Argen X NV

(ARGNF)

By |

Profile

argenx SE is a clinical stage biotechnology company. It is engaged in the business of developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. Its product pipeline includes product candidates such as ARGX-113, ARGX-110, ARGX-115, ARGX-112 etc. The company operates in Netherlands, Germany, Denmark, Belgium, Switzerland, United States and Luxembourg. It derives the majority of its revenues from Switzerland.

Contact Information

Website: www.argenx.com
Email: info@argenx.com
Main Phone: +31 763030488
Address: Willemstraat 5
City / Town: Breda
Country: NLD
Postal Code: 4811

Issuer Information

Exchange: GREY
CEO: Tim Van Hauwermeiren
Employees: 73
$ 74.29 $ 0. (0.00%)
Last Price 74.29 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 74.29
Last Trade Volume 0 52 Wk Hi 85.00 52 Wk Low 51.75
Market Cap 2.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 35,928,544.00 EPS (TTM) -1.66 PE Ratio N/A Exchange Greys